Skip to main content

Advertisement

Open Access
Open Peer Review

This article has Open Peer Review reports available.

How does Open Peer Review work?

Chotosan ameliorates cognitive and emotional deficits in an animal model of type 2 diabetes: possible involvement of cholinergic and VEGF/PDGF mechanisms in the brain

  • Qi Zhao1,
  • Yimin Niu1,
  • Kinzo Matsumoto1Email author,
  • Koichi Tsuneyama2,
  • Ken Tanaka3,
  • Takeshi Miyata4, 5 and
  • Takako Yokozawa6
BMC Complementary and Alternative MedicineThe official journal of the International Society for Complementary Medicine Research (ISCMR)201212:188

DOI: 10.1186/1472-6882-12-188

Received: 2 July 2012

Accepted: 18 October 2012

Published: 20 October 2012

Back to article

Open Peer Review reports

Pre-publication versions of this article and author comments to reviewers are available by contacting info@biomedcentral.com.

Original Submission
2 Jul 2012 Submitted Original manuscript
Resubmission - Version 2
Submitted Manuscript version 2
4 Jul 2012 Author responded Author comments - Kinzo Matsumoto
Resubmission - Version 3
4 Jul 2012 Submitted Manuscript version 3
27 Jul 2012 Reviewed Reviewer Report - Masayuki Hiramatsu
28 Aug 2012 Reviewed Reviewer Report - ZHI-ZHONG MA
26 Sep 2012 Author responded Author comments - Kinzo Matsumoto
Resubmission - Version 4
26 Sep 2012 Submitted Manuscript version 4
13 Oct 2012 Reviewed Reviewer Report - Masayuki Hiramatsu
Resubmission - Version 5
Submitted Manuscript version 5
Publishing
18 Oct 2012 Editorially accepted
20 Oct 2012 Article published 10.1186/1472-6882-12-188

How does Open Peer Review work?

Open peer review is a system where authors know who the reviewers are, and the reviewers know who the authors are. If the manuscript is accepted, the named reviewer reports are published alongside the article.. All previous versions of the manuscript and all author responses to the reviewers are also available.

You can find further information about the peer review system here.

Authors’ Affiliations

(1)
Division of Medicinal Pharmacology, Institute of Natural Medicine, University of Toyama
(2)
Department of Diagnostic Pathology, Graduate School of Medical and Pharmaceutical Sciences, University of Toyama
(3)
Division of Pharmacognosy, Institute of Natural Medicine, University of Toyama
(4)
Division of Biomedical Informatics, Institute of Natural Medicine, University of Toyama
(5)
Laboratory of Presymptomatic Medical Pharmacology, Faculty of Pharmaceutical Sciences, Sojo University
(6)
Collaboration Division, Organization for Promotion of Regional Collaboration, University of Toyama

Advertisement